Advance in clinical application of methylene blue

CHEN Si-qin,WANG Ying-wei
DOI: https://doi.org/10.3969/j.issn.1674-8115.2008.02.026
2008-01-01
Abstract:As an inhibitor of guanylyl cyclase, methylene blue can reduce the production of intracellular cyclic guanosine monophosphate (cGMP), and eventually prevent the relaxation of vascular smooth muscle mediated by excess nitric oxide. Administration of methylene blue is able to increase mean arterial blood pressure and systemic vascular resistance, and reduce the need for vasopressors. Besides, it can enhance myocardial contractility, decrease serum lactate levels, and provide more favorable tissue perfusion. The paper reviews the mechanism and clinical application of the above characteristics of methylene blue.
What problem does this paper attempt to address?